Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells
Clinical trial NCT05208060 · UNKNOWN
Trial details
- NCT number
- NCT05208060
- Sponsor
- Inmunotek S.L.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-01-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.